Announcements Trials
Browse Landscape

Phase

Phase 3 10Phase 2 6Phase 1/2 4Phase 1 3Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 2Phase NA 1

Status

Withdrawn 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other neoplasm 1Head & Neck 1Gastrointestinal 1

Conditions

Pancreatic Adenocarcinoma 1Malignant Neoplasm in the Head and Neck 1Lung Metastases 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Ethiodized Oil × Clear all
NCT04200417 2025-05-16

Chemoembolization for Lung Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
10 enrolled
Thoracic

Lung Metastases

NCT05490381 2023-12-12

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

University of Washington

Phase 1 Withdrawn
Head & NeckOther neoplasm

Malignant Neoplasm in the Head and Neck

NCT03865563 2020-01-27

Selective Transvenous Chemoembolization of Primary Pancreatic Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Withdrawn
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡